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Abstract

Genomic alterations have been linked to the development and progression of cancer. The technique of Comparative Genomic Hybridization (CGH) yields data
consisting of fluorescence intensity ratios of test and reference DNA samples. The
intensity ratios provide information about the number of copies in DNA. Practical
issues such as the contamination of tumor cells in tissue specimens and normalization errors necessitate the use of statistics for learning about the genomic alterations from array-CGH data. As increasing amounts of array CGH data become
available, there is a growing need for automated algorithms for characterizing genomic profiles. Specifically, there is a need for algorithms that can identify gains
and losses in the number of copies based on statistical considerations, rather than
merely detect trends in the data.
We adopt a Bayesian approach, relying on the hidden Markov model to account
for the inherent dependence in the intensity ratios. Posterior inferences are made
about gains and losses in copy number. Localized amplifications (associated with
oncogene mutations) and deletions (associated with mutations of tumor suppressors) are identified using posterior probabilities. Global trends such as extended
regions of altered copy number are detected. Since the posterior distribution is
analytically intractable, we implement a Metropolis-within-Gibbs algorithm for
efficient simulation-based inference. Publicly available data on pancreatic adenocarcinoma, glioblastoma multiforme and breast cancer are analyzed, and comparisons are made with some widely-used algorithms to illustrate the reliability and
success of the technique.
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Abstract
Genomic alterations have been linked to the development and progression of cancer. The technique
of Comparative Genomic Hybridization (CGH) yields data consisting of fluorescence intensity ratios
of test and reference DNA samples. The intensity ratios provide information about the number
of copies in DNA. Practical issues such as the contamination of tumor cells in tissue specimens
and normalization errors necessitate the use of statistics for learning about the genomic alterations
from array-CGH data. As increasing amounts of array CGH data become available, there is a
growing need for automated algorithms for characterizing genomic profiles. Specifically, there is a
need for algorithms that can identify gains and losses in the number of copies based on statistical
considerations, rather than merely detect trends in the data.
We adopt a Bayesian approach, relying on the hidden Markov model to account for the inherent
dependence in the intensity ratios. Posterior inferences are made about gains and losses in copy
number. Localized amplifications (associated with oncogene mutations) and deletions (associated
with mutations of tumor suppressors) are identified using posterior probabilities. Global trends
such as extended regions of altered copy number are detected. Since the posterior distribution is
analytically intractable, we implement a Metropolis-within-Gibbs algorithm for efficient simulationbased inference. Publicly available data on pancreatic adenocarcinoma, glioblastoma multiforme and
breast cancer are analyzed, and comparisons are made with some widely-used algorithms to illustrate
the reliability and success of the technique.

1

INTRODUCTION

The genomics of cancer. The normal DNA of human females has two copies of the entire genomic code
because there are 23 matched pairs of chromosomes. Human males have 22 matched pairs of non-sex (or autosomal) chromosomes and an unmatched pair of sex chromosomes. Hence the copy number of normal male DNA
is two for the autosomal chromosomes. The ends of the chromosomes are called the telomeres. The telomere
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corresponding to the short arm of a chromosome is called the p telomere, while the one corresponding to the long
arm is called the q telomere.
Human cells can be classified into somatic (or body) cells and germ cells. Barring a few exceptions like red
blood cells, muscle cells and brain cells, the life cycle of somatic cells consists of a period of growth followed
by cell division through mitosis. Cells must satisfy certain “quality control checks” before they can progress to
a subsequent stage of the cycle. These checks ensure that the cells develop normally, that defects are repaired
and that DNA is correctly copied during mitosis. Two kinds of genes play very important roles in the regulation
procedure: proto-oncogenes and tumor-suppressors. Proto-oncogenes encourage the body cells to grow and divide,
pushing them through the quality control check points. Tumor-suppressors tend to hold the cells back, inhibiting
mitosis when there are cell defects, and signaling the cells to die when their lifespans have ended or when there
are cell defects that cannot be repaired. Further details about the relevant biology for this problem are given in
Pasternak (1999).
Occasionally, proto-oncogenes may mutate into oncogenes. The mutations are propagated to new cells through
mitosis. Oncogenes duplicate themselves through several stages of mitosis so that cells end up with multiple copies
of oncogenes. Oncogenes have a dominant effect on the cell function, causing the cells to divide at a rapid rate and
resulting in the development of tumors. Tumors may also develop due to mutations in tumor-suppressors that
cause them to become non-functional and allow the proto-oncogenes to play a dominant role. Tumor-suppressor
mutations eventually result in the loss of one or both copies of the gene. A deletion is the loss of both copies in
a genomic region.
A single mutation is usually not enough to trigger cancer. A number of complex biological events occur before
a person acquires the phenotype of cancer. An example, but not a necessary condition, is the ability of tumor cells
to metastasize making the tumor malignant. Not all the cells in a tumor specimen necessarily exhibit the same
kind of genomic alteration. Additionally, there is a lot of variation among individuals. As the disease progresses,
there are larger-scale changes in tumor DNA because of the breakdown of quality control in cell division.
Copy number changes, or alterations in the number of copies in tumor DNA, are therefore closely associated
with the development and progression of cancer. A number of methods are currently available to detect genomic
changes. Karyotyping views the chromosomes through a microscope during the metaphase stage of the cell cycle.
This technique covers the entire genome but has low resolution because only the changes spanning large regions
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of the DNA, such as missing chromosomes, monosomies (loss of single copies) and trisomies (gain of additional
copies of chromosomes) can be detected by this method. At the other end of the spectrum, molecular genetic
studies are capable of single base pair resolution. Since the genome consists of approximately 3 billion bases, this
technique cannot be used in the absence of prior knowledge to identify the DNA regions associated with a disease.
Researchers must rely on other methods to first identify candidate loci involved in the disease pathogenesis.

Array-CGH. Comparative Genomic Hybridization (CGH) has emerged as a powerful technique because it
combines relatively high resolution of a few million bases with the ability to span the entire genome in a single
experiment (Kallioniemi et al. 1992). Fragmented DNA from a test sample is labeled with fluorochrome (typically
Cy3) and is mixed with normal DNA that is identically fragmented but labeled using a different (typically Cy5).
The normal and tumor DNA fragments are simultaneously hybridized to a normal metaphase spread. Image
analysis yields data consisting of fluorescence intensity ratios along the genomes of the test and reference DNA
samples. The more recently developed array-CGH techniques (Solinas-Toldo et al., 1997; Pinkel et al., 1998;
Snijders et al., 2001; Pinkel and Albertson, 2005) hybridize the DNA fragments or “clones” to mapped array
fragments rather than metaphase chromosomes. CGH arrays that rely on BAC (bacterial artificial chromosome)
clones have a resolution of the order of 1 Mb (one million base pairs). Oligonucleotide and cDNA arrays (Pollack
et al., 1999; Brennan et al., 2004) provide a higher resolution of 50–100 kb (1 kb = thousand base pairs). As with
all microarray-based techniques, the fluorescence intensity ratios have to be normalized as part of a pre-processing
step to correct for non-biological sources of error such as intensity fluctuations, background noise and fabrication
artifacts (Brown et al., 2001; McLachlan et al., 2004). Refer to Khojasteh et al. (2005) for a comparison of
different normalization methods for array-CGH data.
Array-CGH intensity ratios (equivalently, their transformation on the log2 scale) provide much useful information about genome-wide changes in copy number. Imagine an idealized situation where all the cells in a tumor
specimen have identical genomic alterations and are uncontaminated by cells from surrounding normal tissue. In
the absence of normalization or measurement errors, the normal (or copy-neutral) clones would correspond to a
log2 ratio of zero because the normal and tumor DNA fragments both have two copies. The log-intensity ratios
of single copy losses would be exactly log2 1/2 = −1 and those of single copy gains would be log2 3/2 = 0.58.
Multiple copy gains or amplifications, often associated with oncogenes, would correspond to data belonging to
the sequence: log2 4/2, log2 5/2, . . .. Losses of both copies or deletions, often associated with tumor-suppressor
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mutations, would correspond to a value of −∞. In this hypothetical situation, the genomic alterations can be
easily deduced from the data without statistical techniques.
For comparison with the above idealized scenario, Figure 1 plots the normalized log2 ratios of breast cancer
specimen S0034 analyzed by Snijders et al. (2001). The data are available from Web Table J at http://www.nature.com
/ng/journal/ v29/n3/suppinfo/ ng754 S1.html Although relatively clean by array-CGH standards, the data
highlight some of the issues that necessitate the use of statistical methods. For example, even after accounting
for measurement error, the log2 ratios differ considerably from the theoretical values. In particular, the numbers
are typically shrunk toward zero. This is caused by several factors including contamination of the tumor sample
with normal cells. There is a more subtle effect of the zero varying slightly from chromosome to chromosome due
to normalization errors. There is also an obvious dependence among the intensity ratios of neighboring clones.
As increasing amounts of array-CGH data become available, there is a need for automated algorithms for
characterizing the genomic profiles. A number of well-known methods strive to fulfil this need. For example,
Pollack et al. (2002) propose a threshold method for identifying clones having extreme value of emissions. Cheng
et al. (2003) discuss a regression-based test for altered copy numbers. Hodgson et al. (2001) use a normal
mixture of three components to model the observed emissions. Olshen et al. (2004) develop a variation of
binary segmentation to identify chromosomal segments with altered copy numbers. Fridlyand et al. (2004) apply
an unsupervised hidden Markov model. Wang et al. (2005) build hierarchical clustering-style trees along each
chromosome and select interesting clusters by controlling the False Discovery Rate. Jong et al. (2003) propose a
break point model to segment the clones. Eilers and de Menezes (2005) apply quantile smoothing method, while
Huang et al. (2005) use penalized least squares regression and Hsu et al. (2005) apply wavelets. Hupe et al. (2004)
rely on a likelihood function with adaptively determined weights using a smoothed version of the data. Picard
et al. (2005) use a penalized likelihood function. Myers et al. (2004) apply an edge filter to detect the segments.
Lingjaerde et al. (2005) perform smoothing using the signs of neighboring data values, inspecting the width and
magnitude of the segments to detect regions of copy number change.
A recent paper by Lai et al. (2005) makes comparisons of some of the above algorithms using real and
simulated data. In evaluating the algorithms, Lai and co-authors comment that “a particularly helpful feature for
future implementations of some algorithms would be to estimate the statistical significance of the detected copy
number changes and then rank them accordingly.” They point out that only two algorithms (those of Wang et
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al., 2005 and Lingjaerde et al., 2005) can actually detect copy number changes based on statistical significance.
Both methods rely on false discovery rates.
In Section 2, we develop a statistical framework for detecting copy number gains and losses, identifying
localized amplifications and deletions, and partitioning tumor DNA into regions of relatively stable copy number.
We rely on the hidden Markov model (HMM) to account for the dependence between neighboring clones. We
adopt a Bayesian approach, assuming informative priors for the model parameters that are flexible enough to allow
Bayesian learning. Since the posterior distribution is analytically intractable, Section 3 develops a framework for
simulation-based posterior inference. In Section 4, we demonstrate the success of the technique using publicly
available data. Section 4.4 compares the proposed Bayesian HMM with some of the existing algorithms using the
framework of Lai et al.˜(2005).
Unlike the HMM of Fridlyand et al., which is purely a segmentation method, the likelihood function of Section
2.1 allows the use of objective decision rules based on posterior probabilities to detect copy number alterations.
Unlike most of the existing array-CGH methods, the biologist is not required to subjectively decide, after the
algorithm’s output has been obtained, plausible thresholds for identifying changes in the number of DNA copies.
The proposed framework allows the use of the simple classification scheme of Section 3.1, which is motivated
by biological considerations and which makes the algorithm output easy to interpret. Section 5 uses simulation
studies to compare the Bayesian HMM with alternative techniques for analyzing array-CGH data.

2
2.1

BAYESIAN HIDDEN MARKOV MODEL

Likelihood function

Since the propensity for genomic alterations varies across the chromosomes, we allow each chromosome to have a
distinct set of parameters. For a given chromosome, let L1 , . . . , Ln represent the mapped clones or DNA fragments
arranged from the p-telomere to the q-telomere. Let Yk denote the normalized log2 ratio observed at clone Lk .
As mentioned earlier, the aim of the analysis is to learn about genome-wide changes in copy number from
the data. A key innovation that directly achieves this goal is a latent variable called the copy number state sk
associated with each clone Lk , where k = 1, . . . , n. The variable sk takes values in the set {1, 2, 3, 4}. The value
sk = 1 represents a copy number loss at Lk that could be either a single copy loss or a deletion; sk = 2 represents
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the copy-neutral state; sk = 3 represents a single copy gain; sk = 4 represents an amplification (i.e. multiple
copy gain) at Lk . The parameters of interest that summarize the copy number changes on the chromosome are
s1 , . . . , sn .
For j = 1, . . . , 4, we define µj as the expected log2 ratio of all clones Lk for which sk = j. For example,
the expected log2 ratio of single copy gains is µ3 . The theoretical value of µ3 is 0.58, but as mentioned earlier,
the actual value could be different for many reasons, e.g. contamination of tumor samples with normal tissue.
Although the µj ’s are unknown parameters, the biological interpretation associated with the state space of sk
allows us to assume the ordering: µ1 < µ2 < µ3 < µ4 . Conditional on the copy number states, the normalized
indep

log2 ratios are assumed to be distributed as Yk ∼ N (µsk , σs2k ), where k = 1, . . . , n.
We model the dependence of the neighboring clones using a hidden Markov model (Rabiner, 1989; MacDonald
and Zuchchini, 1997; Durbin et al., 1998). For any m indices for which 1 ≤ k1 ≤ . . . ≤ km ≤ n, a Markov
£
¤
£
¤
model for the copy number states assumes that Pr skm | s1 , . . . , skm−1 = Pr skm | skm−1 . The hidden Markov
model (HMM) assumes that the conditional probabilities of neighboring clones is Pr [sk+1 | sk ] = ask sk+1 where
A = ((aij )) is the matrix of stationary transition probabilities. We assume that the elements of A are strictly
positive. The hidden Markov process is then aperiodic, irreducible and its four states are positive recurrent.
Transition matrix A has a unique stationary distribution, denoted by πA = (πA (1), πA (2), πA (3), πA (4)), where
πA (i) is strictly positive for state i = 1, · · · , 4 (Karlin and Taylor, 1981). We also assume that s1 , the copy
number state of the first clone, is distributed as πA . Together with the hidden Markov assumption, this uniquely
determines the joint likelihood of a given sequence s1 , . . . , sn . The chromosome-specific hyperparameters are
therefore the transition probability matrix A, means {µ1 , µ2 , µ3 , µ4 } and error variances {σ12 , σ22 , σ32 , σ42 }.

2.2

Priors

The Bayesian approach assumes priors for all unknown parameters. Since the copy number states defined in
Section 2.1 have a well-defined meaning, this facilitates the use of informative priors based on our knowledge of
array-CGH data. For example, we know that the mean µ1 of copy number losses cannot be a positive number,
although individual log2 ratios that correspond to copy number losses could be. Independent priors are assumed
for the chromosome-specific parameters. This results in independent posteriors for all the chromosomes. The
marginal posterior [s1 , . . . , sn | Y1 , . . . , Yn ] is of interest. As with many Bayesian applications, the marginal
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posterior cannot be analytically computed and so simulation-based techniques are necessary. While analyzing
HMMs, a key issue is label switching (refer to Scott, 2002 for a discussion). This is an identifiability issue where
the likelihood is invariant under arbitrary permutations of the state space labels, resulting in inefficient exploration
of the posterior by simulation. The likelihood of Section 2.1 avoids this problem by assuming order constraints.
Specifically, the constraint µ1 < µ2 < µ3 < µ4 is violated on permutating the labels.
Let X ∼ F · I(c < X < d) imply that X has the distribution F restricted to the interval (c, d) with
the density suitably rescaled to make it a random variable. For the mean µ1 corresponding to copy number
¡
¢
losses, we assume the prior µ1 ∼ N −1, τ12 · I (µ1 < −²) where ² > 0. We comment below on the choice of ².
¡
¢
For the copy-neutral state, we assume µ2 ∼ N 0, τ22 · I (−² < µ2 < ²). For single copy gains, we assume µ3 ∼
¡
¢
¡
¢
N 0.58, τ32 ·I (² < µ3 < 0.58), and for multiple copy gains, we assume [µ4 | µ3 , σ3 ] ∼ N 1, τ42 ·I (µ4 > µ3 + 3σ3 ).
These informative priors were chosen as follows. For µ2 and µ3 , the means of the untruncated distributions are
set equal to the theoretical values for pure samples. For µ1 (µ4 ), the untruncated distribution is centered at
the theoretical value for a loss (gain) of one copy. The lower endpoint of the support of µ4 is chosen to be
3σ3 units away from µ3 so that a small fraction of single copy gains are erroneously classified as multiple copy
gains. The results are not sensitive to choices of τ1 , τ2 and τ3 belonging to the interval [0.5, 2]. Setting τ4 ≤ 2
guarantees sufficiently high prior probability to large values of µ4 associated with high-level amplifications. We
set τ1 = τ2 = τ3 = 1 and set τ4 = 2 in Sections 4 and 5.
Unlike a threshold-based approach for detecting changes in copy number, the constant ² determines the
boundaries for the means µj rather than for the log2 ratios. These boundaries are not the same as threshold
levels for detecting gains and losses. In fact, our assumptions allow positive log-intensity ratios for copy number
losses, especially with large measurement errors, although µ1 itself cannot exceed −². In our analyses of actual
array-CGH data, we have found the results to be robust to choices of ² in the range [0.05, 0.15]. This is shown by
verified in Section 5.2. For all our analyses, we set ² = 0.1.
For the measurement error precisions, we assume the priors σj−2 ∼ gamma (1, 1) · I(σj−2 > 6) for j = 1, 2, 3,
and σ4−2 ∼ gamma (1, 1). For the states j = 1, 2, 3, the assumption σj−2 > 6 is equivalent to σj < 0.41. This
assumption is mild because typical array-CGH data suggest much lower within-group variability for the states 1,
2 and 3. The support of σ4−2 is not bounded below because state 4 is an aggregation of multiple copy gains which
usually results in a higher within-group variability (i.e. smaller precision).
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We assume independent Dirichlet priors on <4 for the rows of the stochastic matrix A, since this distribution
has the set of all probability 4-tuples as its support. That is, with ai denoting the ith row of matrix A, we assume
that ai

indep

∼ D4 (θi1 , θi2 , θi3 , θi4 ) where i = 1, · · · , 4 and the constants {θij } are positive. As shown in Section

5.2, the results are not affected by the choices of θij that are small in comparison to n. We fixed the θij ’s equal
to one in Sections 4 and 5.
The above priors are found to work consistently well for array-CGH data. They are flexible enough to allow
Bayesian learning and information sharing across the clones. We find in Sections 4 and 5 that the posterior
inference is reliable and sensitive to the characteristics of the data.

3

CHARACTERIZING ARRAY-CGH PROFILES

We rely on simulation-based methods for inference because the posterior distribution cannot be investigated
by mathematical analysis or numerical integration. An efficient Metropolis-within-Gibbs algorithm for generating
posterior samples of the parameters is given in the Appendix. The algorithm generates the parameters in blocks
conditional on the remaining parameters and the data. The transition matrix A is generated using an independentproposal Metropolis-Hastings algorithm. The copy number states are simulated by a stochastic version of the
forward-backward algorithm (Chib, 1996; Robert, Ryden and Titterington, 1999) that mixes faster than a Gibbs
sampler (refer to Scott, 2002). The remaining model parameters are generated by Gibbs sampling. The algorithm
has been implemented using R and will soon be publicly available.

3.1

Classification scheme

The generated copy number states represent draws from the marginal posterior of interest, [s1 , . . . , sn | Y1 , . . . , Yn ].
For each MCMC draw, the generated states are inspected and, possibly non-exclusively, classified as focal aberrations, transition points, amplifications, outliers and whole chromosomal changes. In the following discussion,
altered state refers to a copy number state which is different from 2:
1. Focal aberrations represent localized regions of altered copy number: (i) a single clone not belonging
to a telomere having an altered state different from its neighbors, (ii) two clones belonging to a telomere
sharing a common altered state different from that of the third clone from the telomere, or (iii) two or
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more adjacent clones mapped within 5 Mb having a common altered state different from their neighbors.
Focal aberrations are used to detect transition points and outliers (defined below).
2. Transition points can be regarded as a property of the n − 1 inter-clonal spaces on the chromosome.
An inter-clonal space is a transition point if it borders on two large regions associated with different copy
number states. In contrast, focal aberrations represent small regions of altered copy number. A transition
point is an inter-clonal space for which both of these conditions hold: (i) it is not adjacent to a telomere,
and (ii) after excluding all focal aberrations on the chromosome, the neighboring clones on both sides of
the inter-clonal space have different copy number states.
Transition points are different from segments. Transition points differ from “segments” defined by the
CBS algorithm of Olshen et al. (2004), an outstanding algorithm (refer to Lai et al., 2005) for analyzing
array-CGH data. The CBS algorithm segments clones regardless of their spacing on the chromosome. A
transition point, on the other hand, is associated with large-scale regions of gains and losses, and is declared
only when the width of the altered region exceeds 5 Mb. For example, five contiguous clones that are highly
amplified would generally be identified as a segment by the CBS algorithm (although there are examples
in Section 4 where the procedure ignores obvious amplification and deletions to control the false positive
rate). In contrast, if these five clones are located within 5 Mb, the Bayesian HMM algorithm labels them
as focal aberrations rather than identify them as a separate region.
3. High-level amplifications. A clone for which sk = 4.
4. Outliers. An outlier is a focal aberration satisfying: (i) sk = 1 and (Yk − µ1 )/σ1 < −2, or (ii) sk = 3
and (Yk − µ3 )/σ3 > 2. Type-(i) outliers could be associated with mutations on tumor suppressors and are
labeled as deletions. Type-(ii) outliers may be associated with oncogene mutations.
5. Whole chromosomal changes. The entire chromosome is identified as gained or lost if all the clones
except the focal aberrations have altered copy number states.

3.2

Posterior inference

For a given clone, the classification scheme of Section 3.1 results in a Bernoulli variable for each MCMC iterate
and type of genomic alteration. For example, the k th clone is classified as a focal aberration (“1”) for some
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MCMC draws and as “0” for the remaining draws. The probability that this Bernoulli variable equals one is the
posterior probability that clone Lk is a focal aberration. For a sufficiently large number of MCMC samples, the
average of these binary outcomes is a simulation-consistent estimate of the posterior probability. Therefore, we
declare clone Lk to be a focal aberration if this posterior probability exceeds 0.5, which is the Bayes decision rule
corresponding to a 0-1 loss function (Berger, 1985, pp. 164). A similar method is used to identify deletions. Whole
chromosomal changes correspond to a common Bernoulli outcome for all n clones. A chromosomal alteration is
declared if the posterior probability of a chromosome-wide alteration exceeds 0.5.
High-level amplifications could be detected by a similar method. However, a more efficient method is available
as a by-product of the forward-backward algorithm, which computes the conditional probability that sk = 4 given
the hyperparameters and the data. Averaging these conditional probabilities over the MCMC sample gives a
simulation-consistent estimate of the posterior probability that clone Lk is a high-level amplification.
We have noticed a potential problem with identifying transition points based on the marginal posterior
probabilities of the inter-clonal gaps. We recommend detecting the change points based on the configuration of
change points having the highest joint posterior probability. Formally, let us write the configuration of change
points as ν(s) = (g1 , . . . , gn−1 ), where gj equals one if the j th inter-clonal gap is a change point, and equals zero
otherwise. Notice that the mapping from s to ν(s) is many-one. The posterior distribution of ν(s) is maximized
to compute ν ∗ , the configuration having the highest posterior probability. A simulation-consistent estimate of ν ∗
is computed using the MCMC sample and is used to detect the transition points.
Summary tables and plots that are of direct interest to the biologist can now be constructed. Large-scale and
localized regions of copy number change identified by the Bayesian HMM algorithm can be important tools for
identifying candidate genes associated with cancer.

4
4.1

ILLUSTRATIONS

Pancreatic adenocarcinoma data

Pancreatic adenocarcinoma is among the most lethal of cancers. The disease is characterized by a high level
of genomic instability from the earliest stages of the disease (Gisselsson et al., 2000 and 2001; van Heek et al.,
2002). Genomic changes identified in the progression of the disease include early-stage mutations in the oncogene
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KRAS and later-stage losses of the tumor supressors p16IN K4A , p53 and SM AD4 (Bardeesy and DePinho, 2002).
Using a variety of techniques ranging from karyotype analyses, CGH and loss of heterozygosity mapping, frequent
gains and losses have been mapped to regions on chromosomes 3–13, 17, 18, 21 and 22 (Johansson et al., 1992;
Solinas-Toldo et al., 1996; Mahlamaki et al., 1997 and 2002; Seymour et al., 1994, among many others).
Aguirre et al. (2004) studied the array CGH profiles of 24 pancreatic adenocarcinoma cell lines and 13 primary
tumor specimens. In that paper, the profiles were individually analyzed using the CBS algorithm of Olshen et
al. (2004), which segments the data and computes the within-segment means but does not detect gains or losses.
The CBS algorithm was first run on the unnormalized log2 ratios to obtain the distribution of the within-segment
means. The tallest mode of the distribution was subtracted from the data to compute the normalized log2 ratios,
which are available at http://genomic.dfci.harvard.edu/ array cgh.htm. Setting thresholds in an ad-hoc
manner, Aguirre et al. (2004) and declared normalized log2 ratios greater than 0.13 in magnitude as copy number
changes (gains or losses), greater than 0.52 as high-level amplifications, and less than −0.58 as deletions. They
also defined objective criteria for comparing the copy number alterations of individual array-CGH profiles. These
criteria were applied to analyze the 37 tumor samples and to identify 54 frequently altered minimal common
regions (MCRs) associated with pancreatic adenocarcinoma. In a subsequent study, candidate genes located
within the MCRs were confirmed by the analysis of expression profiles.
We applied the Bayesian HMM algorithm to analyze these data and made comparisons with the CBS procedure. The complete set of results are presented in the supplementary materials. Throughout, the Bayesian HMM
is found to perform reliably and compare favorably with the CBS procedure. We discuss a few examples here.
Our primary reference for the MCRs associated with pancreatic cancer is Aguirre et al. (2004).
The upper left panel of Figure 2 displays the result for chromosome 8 of specimen 30. The green horizontal
lines represent the within-segment means computed by the CBS algorithm. The vertical lines correspond to the
transition points identified by the Bayesian HMM. We find that both algorithms picked up the overall trend
in the data. However, while the end-user (often a biologist with relatively little statistical training) decides
whether or not the CBS algorithm’s within-segment means correspond to copy number changes, the Bayesian
HMM automatically identified the first region as primarily copy-neutral and the second region as consisting of
mainly single-copy gains.
In the upper right panel of Figure 2, the CBS procedure declared the first set of high intensity ratios on
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chromosome 12 of specimen 6 as two separate segments. This is because the CBS procedure identifies trends in
the data. The Bayesian HMM, on the other hand, is motivated from the perspective of copy number change.
It declared these clones as high-level amplifications and therefore as a single region. The next set of clones
having lower log2 ratios were identified as focal aberrations because they are localized changes less than 2 Mb
in width. The two amplified regions detected by the Bayesian HMM correspond to the two minimal common
regions (MCRs) on chromosome 12 associated with copy number gains (see Table 1 of Aguirre et al.) The first
MCR contains the KRAS2 gene, point mutations of which occur in more than 75% of pancreatic cancer cases
(Almoguera et al., 1988). The CBS algorithm failed to detect the second MCR.
The bottom left panel of Figure 2 displays the profile for chromosome 17 of specimen 13. The region from
17p13.3 to 17q11.1 (10.36 Mb to 12.8 Mb) contains the tumor supressors p53 and M KK4. Mutations on the
gene p53 are found in at least 50% of pancreatic adenocarcinoma cases (Caldas et al., 1994). The single probe
corresponding to this region was easily detected by the Bayesian HMM as a deletion. In contrast, the CBS
algorithm effectively declared the entire chromosome as copy-neutral.
The bottom right panel presents the array-CGH profile of chromosome 18 of specimen 2. The Bayesian HMM
algorithm detected an outlier associated with a copy number loss around 48 Mb. The outlier corresponds to
the SM AD4 tumor suppressor gene located at 18q21, a mutation on which is associated with pancreatic cancer
(Bardeesy and DePinho, 2002). Aguirre and co-authors mention that the CBS procedure completely missed the
well-established association with the SM AD4 gene, even though it was clearly visible in several specimens of the
data set.
The CBS procedure often ignores obvious single-probe aberrations to control the False Discovery Rate. Such
errors can be misleading, because subsequent gene validation involves experimental techniques that are much
more expensive than CGH. For this reason, single-probe aberrations that are frequently observed across tumor
specimens provide one of the most cost-effective avenues for further research about the underlying causes of cancer.
There are many other instances of the differences between the CBS and Bayesian HMM algorithms. For example,
the MCR from 68.27 to 68.85 Mb on chromosome 12 maps to highly amplified clones in 34 out of 37 specimens
(see the supplementary materials). In every case, the Bayesian HMM declared them as high-level amplifications,
but the CBS procedure detected only the amplification in specimen 8. The Bayesian HMM also outperformed
the CBS algorithm in detecting the mutation on gene FEZ1 in specimen 26, and of the genes OZF and AKT2 in
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specimen 6.
The results demonstrate that the Bayesian HMM is effective not only in detecting global trends, but also
highly localized changes in copy number. This feature is important in identifying genes associated with cancer
(e.g. SM AD4 in the foregoing example) on which the point mutations do not become large-scale genomic changes
as the disease progresses. The algorithm has potential for use as a diagnostic tool during the early stages of cancer.

4.2

Corriel cell lines

The Corriel cell line is widely regarded a “gold standard” data set and analyzed in Snijders et al. (2001).
The data, normalized to the genome-wide median log2 ratio, are available in Web Tables E–H at http://
www.nature.com/ng/ journal/v29/ n3/suppinfo/ng754 S1.html. A table of known karyotypes is presented
in Web Table I on the same website. We compared these cytogenically mapped alterations with the profiles
produced by our algorithm and verified that the results match in all the specimens. For example, for cell line
GM05296, Web Table I reports a trisomy at 10q21–10q24 and a monosomy at 11p12–11p13. The array-CGH
profile for chromosomes 10 and 11 of cell line GM05296 are displayed in Figure 3. The regions of gain and loss
identified by the Bayesian HMM match the karyotypes presented in Web Table I. We omit the results for the
other cell lines for brevity.

4.3

Breast cancer data

A useful feature of the Bayesian approach is that posterior probability plots can be created for the different kinds
of genomic alterations. These plots provide a “bird’s eye view” of the copy number alterations. They are useful
in identifying genomic regions associated with the disease. The procedure can be easily automated for a large
number of genomic profiles. To illustrate, we analyzed the breast cancer data given in Snijders et al. (2001).
The data were normalized by centering to the genome-wide median log2 ratios. The posterior probability plot
for specimen S1514 is displayed in Figure 4. There are several high-level amplifications on chromosome 20 and
deletions on chromosomes 13 and 14. Consistent with Figure 4, a region of high-level amplifications is seen on
the array-CGH profile of chromosome 20 in Figure 5.
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4.4

Comparisons with some existing methods

Using the Glioblastoma Multiforme data of Bredel el al. (2005), Lai et al. (2005) evaluated 11 array-CGH algorithms based on segment detection as well as smoothing. The data was normalized using the Limma package
(Smyth, 2004) and are available at http://www.chip.org/∼ppark/Supplements/ Bioinformatics05b.html.
Graphical summaries of the results are presented in that paper as Figures 3 and 4. Sample GBM31 (Figure 3 of
Lai et al., 2005) exhibits low signal-to-noise ratio. There is a large region of losses on chromosome 13. Lai and
co-authors found that the algorithms CGHseg of Picard et al. (2005), GLAD of Hupe et al. (2004), CBS of Olshen
et al. (2004) and GA of Jong et al. (2003) segmented chromosome 13 into two regions and detected the region of
copy number loss. Smoothing-based methods like lowess, the quantreg algorithm of Eilers and de Menezes (2005)
and wavelet algorithm of Hsu et al. (2005) were sensitive to local trends but were less effective in detecting global
trends. The HMM algorithm of Fridlyand et al. (2004) did not find any segments.
We followed an identical evaluation procedure to compare the Bayesian HMM with the afore-mentioned
methods. Figure 6 displays the result for sample GBM31. The partitioned regions are the same as those identified
by the CGHseg, CBS, GLAD and GA algorithms. Local changes in the number of copies, identical to those
collectively detected by the GLAD and CGHseg algorithms, are marked as high-level amplifications (N) and
deletions (H).
The second data set investigated in Lai et al. (2005) is a fragment of chromosome 7 from sample GBM29
(refer to Figure 4 of that paper). The data show some high log2 intensity ratios around the EGFR locus.
The algorithms CGHseg, quantreg, GLAD, wavelet and GA separated the data into three distinct amplification
regions. The algorithms CBS, CLAC and ACE (Lingjaerde et al., 2005) detected two distinct regions instead of
three. ChARM (Myers et al., 2004) grouped all the high log2 intensity ratios into a single region. The HMM
algorithm of Fridlyand et al. (2004) did not detect the amplifications.
Figure 7 displays the results for the Bayesian HMM algorithm. The high log2 ratios are identified as highlevel amplifications (N). Unlike the algorithms investigated in Lai et al. (2005), the single clone having a highly
negative value is detected by the algorithm and marked as a deletion. The amplifications are identified as focal
aberrations, rather than as separate regions, because both clusters are less than 5 Mb in width.
We find that the Bayesian HMM algorithm combines the strength of the smoothing-based algorithms in
detecting local features with the strength of the segmentation-based methods in detecting global trends. The
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reliability of the procedure is especially impressive with noisy data.

5
5.1

SIMULATION STUDIES

Comparison with non-Bayesian HMM and CBS algorithms

The frequentist analysis matching the foregoing Bayesian procedure estimates the hyperparameters of the likelihood using the Baum-Welch EM algorithm, iteratively incrementing the likelihood until relative changes in the
hyperparameters become sufficiently small. Conditional on the estimated hyperparameters, the Viterbi algorithm
then computes the aposteriori most likely sequence of states s1 , . . . , sn . This technique is not identical as the nonBayesian HMM of Fridlyand et al. (2004). In particular, the latter technique does not assign biological meanings
to the latent states and cannot directly detect changes in copy number.
To find the global maximum in the 20-dimensional hyperparameter space, the EM algorithm has to be run
from several starting points. For typical array-CGH data, each run often requires hundreds of iterations to
converge. Because of this, the computational costs associated with the frequentist and Bayesian analyses are
often comparable. When R is used as the computing platform, the CBS algorithm is considerably faster than
either method. However, all three approaches are computationally feasible and have negligible costs compared to
the many months of experimental effort required to process the tumor specimens.
The non-Bayesian array-CGH profiles for the Section 4.1 data are presented in the supplementary materials.
A detailed comparison with the Bayesian profiles reveals that the two procedures often gave similar results.
However, there are many profiles for which the answers are noticeably different. Examples of such chromosome–
specimen pairs include (5, 2), (5, 7), (12, 10), (7, 13), (15, 13), (5, 19), (18, 31) and (19, 34). Two of the profiles are
displayed in Figure 9. The non-Bayesian hyperparameter estimates correspond to a greater value of the likelihood
function than the Bayes estimates in all these examples. However, the Bayesian profiles look more reasonable.
We performed a simulation study of the differences between the methods. For each of the afore-mentioned
chromosome–specimen pairs, we obtained signal-to-noise ratios that were typical of array-CGH data by setting the
hyperparameters equal to the Bayes estimates. We then generated the underlying copy number states and data
for n = 200 clones. The Bayesian and non-Bayesian HMMs were applied to infer the latent copy number states.
The procedure was independently replicated 100 times. Table 1 displays the percentage of correctly labeled copy
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number states for the two methods. The Bayesian HMM outperforms the non-Bayesian HMM in all the cases.
Using eight randomly selected chromosome–specimen pairs, but an otherwise identical simulation strategy,
Table 2 compares the CBS algorithm with the Bayesian and non-Bayesian HMMs. The method used by Aguirre
et al. (2004) was applied to declare copy number gains and losses for the CBS algorithm. The Bayesian HMM
outperforms the CBS algorithm, often substantially, in seven cases. The difference is inconclusive in one case.
In six out of eight cases, the Bayesian HMM outperforms the non-Bayesian HMM, with the difference being
inconclusive in one case. These results provide significant evidence in favor of the Bayesian HMM.
The Bayesian HMM is found to benefit from the informative priors of Section 2.2. Prior knowledge about
array-CGH helps the procedure distinguish between competing sets of hyperparameter values that are almost
equally plausible under the likelihood but not under the posterior. For example, consider the frequently encountered situation where there are very few log2 ratios are assigned to one or more copy number state. In such a
situation, the likelihood alone may be unable to distinguish between the matching non-Bayesian HMM and a
model having fewer than four states. This results in likelihood-based estimates where one or more of the µj ’s are
approximately equal. Because of the well-defined meanings assigned to the four states of the HMM, the sequence
of copy number states assigned by the non-Bayesian model often seem incorrect in such cases. The Bayesian
approach is more robust in such situations. The informative priors prevent even states having very few probes
and log2 ratios having a considerable amount of overlap due to high measurement error from being classified as
a common state. For some data, a model having fewer states than four may be better-fitting than the proposed
model. However, the states might not have a simple biological interpretation in terms of copy number change.
The detection of copy number gains and losses, which is one of the main goals of the analysis, may also be less
straightforward.
Several examples in Section 4.1 suggest that the Bayesian HMM is better than the CBS algorithm in detecting
amplifications that are localized to a small number of probes. This advantage is of practical importance, because
single-probe amplifications frequently occurring across specimens are often the focus of future, more expensive
gene validation studies. To investigate the difference by a controlled simulation, we independently generated 25
data sets using the following procedure: (i) Fifty out of n = 200 clones were randomly chosen to be amplifications
having a mean signal of 2 on the log2 scale. (ii) The remaining clones were assumed to be copy-neutral with a
mean signal of zero. (iii) The data were generated by adding Gaussian noise with a standard deviation of 0.1 to
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these means.
The high signal-to-noise ratio (SN R) of 20 is atypical of array-CGH data. The percentage of amplified probes
(25%) is also very high. However, in spite of these features that simplify the detection of copy number change,
the CBS algorithm failed to detect any amplification. The Bayesian HMM on the other hand, correctly identified
all the amplifications. Unsurprisingly for such a high SN R, the false discovery rate of the Bayesian HMM was
zero for all the data sets and the average true discovery rate exceeded 99%.

5.2

Prior sensitivity

The preceding analyses assumed that ² = 0.1 for the supports of the µj ’s (refer to Section 2.2) and that θij = 1 for
the priors of the transition matrix rows, where i = 1, . . . , 4 and j = 1, . . . , 4. To alleviate concerns that the results
are sensitive to the choice of ², we generated 100 data sets with n = 500 clones each. For each data set, the true
means µ1 , . . . , µ4 were uniformly generated from narrow intervals centered respectively at −0.5, 0, 0.5 and 1. The
standard deviations σj were uniformly generated in the interval [0.2, 0.25] which is typical of noisy array-CGH
data. The true transition matrices were simulated as follows. For row 2 corresponding to the copy-neutral state,
the off-diagonal elements were uniformly generated in the intervals [0.01, 0.02]; for the remaining rows, the offdiagonal elements were uniformly generated in the intervals [0.02, 0.05]. These nine elements uniquely determined
the row-stochastic transition matrix. For k = 1, . . . , 500, the copy number states sk were then generated and the
data were obtained by adding Gaussian noise to the means µsk .
For ² belonging to a grid of points in the interval [0.05, 0.15], the Bayesian HMM was used to analyze each
simulated data set. The posterior expectations of the means µj , the true discovery rates and false discovery rates
were found to be robust to the choice of ². Figures 8 plots the estimates of µ1 , . . . , µ4 for three randomly chosen
data sets as ² varies. The flatness of the lines provides evidence of the lack of sensitivity to ² ∈ [0.05, 0.15]. The
results were also found to be robust to {θij }i,j that were small compared to n.

6

CONCLUSIONS

We propose a Bayesian hierarchical approach relying on a hidden Markov model for analyzing array-CGH
data. The informative priors allow Bayesian learning from the data. One of the strengths of the fully automated
approach is the ability to detect copy number changes like gains, losses, amplifications, outliers and transition
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points based on the posterior. Summaries of the array-CGH profiles are generated. The profiles can then be
compared across individuals to identify the genomic alterations involved in the disease pathogenesis.
The examples of Section 4 demonstrate the reliability of the Bayesian HMM. The sensitivity of the algorithm
to individual probes often allows us to find candidate genes that are missed by other algorithms. The performance
of the algorithm is impressive not only for the “gold-standard” Corriel cell lines but also for the Glioblastoma
data set of Bredel el al. (2005) having high measurement error. Combined with the results presented in Lai et al.
(2005), the latter analysis reveals a very favorable comparison with outstanding algorithms like those of Picard
et al. (2005) and Olshen et al. (2004). Section 5 compares the Bayesian HMM and alternative algorithms using
controlled simulations. The results confirm the accuracy of the approach.
A strength of the Bayesian HMM is that it relies on essentially no tuning parameters. Unlike many other
algorithms (see Lai et al., 2005), the user is only required to input the normalized log2 ratios. This is a convenient
feature for the end-user with little or no statistical training. In all our analyses, we have used the default
parameterizations specified in Section 2.2. Certain features of the Bayesian HMM may be changed to produce
a different result. Possible features include the constant ² in the prior specification of the means µj and the
constants θij in the transition matrix priors in Section 2.2. However, the simulation study in Section 5.2 and
our own experience with the algorithm indicate that the results are robust to variations in these quantities. The
informative priors for the means µj substantially influence the results, as we find in Section 5.1 on comparing
the Bayesian HMM with the matching non-Bayesian model. However, the order constraints on the µj ’s and the
biological meanings assigned to sk ∈ {1, 2, 3, 4} allow the specification of priors that work consistently well across
different data sets. For this reason, we recommend using the default parameterizations of the Bayesian HMM for
most array-CGH applications.
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APPENDIX
An MCMC algorithm
The following algorithm is independently run for each chromosome to generate an MCMC sample for the chromosomal parameters. We group the model parameters into four blocks, namely, B1 = A, B2 = (s1 , . . . , sn ),
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¡
¢
B3 = (µ1 , µ3 , µ4 ), and B4 = σ 2 , σ42 . The starting values of the parameters are generated from the priors. The
algorithm iteratively generates each of the four blocks conditional on the remaining blocks and the data. Let
(v−1)

B1

(v−1)

, . . . , B4

denote the values of the blocks at the (v − 1)st iteration. In the next iteration, the blocks are

generated as follows:

Updating block B1 . The transition matrix is generated using a Metropolis-Hastings step because the normalizing constant of the full conditional cannot be computed in closed form. This step makes independent
proposals from a distribution that closely approximates the full conditional of the transition matrix. The proposal is accepted or rejected with a probability that compensates for the approximation. Typically, most of the
Metropolis-Hastings proposals are accepted. Using the the copy number states generated at iteration v − 1, we
´
Pn−1 ³ (v−1)
(v)
(v−1)
compute the number of transitions from state i to state j, denoted by uij = k=1 I sk
= i, sk+1 = j ,
where i, j = 1, . . . , 4. We generate a proposal C for the transition matrix from the distributions [ci | Y , B−1 ] ∼
³
´
(v)
(v)
(v)
(v)
D3 1 + ui1 , 1 + ui2 , 1 + ui3 , 1 + ui4 , where row i = 1, . . . , 4, and B−1 denotes the blocks, {B2 , B3 , B4 }. The
proposal ignores the marginal distribution of state s1 and so it differs from the full conditional of the transition
matrix. To compensate for this, we accept the proposal (in other words, set A(v) =C) with probability β, where
o
n
(v−1)
(v−1)
) , and otherwise reject the proposal (in other words, set A(v) =A(v−1) ).
)/πA(v−1) (s1
β = min 1, πC (s1
As defined earlier, πD (s) denotes the probability of state s under the stationary distribution of a given transition
matrix D.

Updating block B2 . The copy number states are generated by a stochastic version of the forward-backward
algorithm. We compute the distribution [sn | B−2 , Y1 , . . . , Yn ] at the beginning of the backward step. We generate
sn from this distribution. The backward step is continued to compute and generate a draw the distribution [sn−1 |
sn , B−2 , Y1 , . . . , Yn ]. The sequence of computing and generating a draw from [sk | sk+1 , B−2 , Y1 , . . . , Yn ] is iterated
for k = n − 2 down to k = 1. This produces a sample from the joint distribution [s1 , . . . , sn | B−2 , Y1 , . . . , Yn ].

Updating block B3 . For s = 1, . . . , 4, let δ0s be the center of the untruncated normal distribution in the prior

³
´
Pn
Pn
(v)
(v)
specification of µs . Compute the sums ns = k=1 I sk = s , averages Ȳs = n1s k=1 Yk · I(sk = s), precisions
·
¸
³ (v−1) ´−2
´−2
³
(v−1) √
σs
. For s = 1, . . . , 4, generate
and weighted means γs = θ12 δ0s · τs−2 + Ȳs · √
θs2 = τs−2 + σs
/ ns
ns
s
h
i
¡
¢
(v)
µs | Y, B−3 ∼ N γs , θs−2 · Is , where the intervals Is denotes the support of the µs (see prior specification).
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Figure 1: Normalized copy number ratios of a comparison of DNA from cell strain S0034 (Snijders et
al., 2001) with normal DNA. The BACs are ordered by position in the genome beginning at 1p and
ending at Xq. The vertical bars indicate borders between chromosomes.
Updating block B4 . For j = 1, . . . , 4, compute nj =
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Figure 2: Array-CGH profiles of some pancreatic cancer specimens. In each panel, the clonal distance
in Mb from the p telomere has been plotted on the x-axis. High-level amplifications and outliers
are respectively indicated by N and H. The broken vertical lines represent transition points. For
comparison, the green lines display the segment means computed by the CBS algorithm. See Section
4.1 for further discussion.
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Figure 3: Array-CGH profile of chromosomes 10 and 11 of Corriel cell strain GM05296. The x-axis
displays the clonal distance from the p telomere in Mb. The broken vertical lines represent transition
points.
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Figure 4: Posterior probabilities of genomic alterations for specimen S1514. The solid line represents
high-level amplifications while the dashed line corresponds to deletions. The numbers on the horizontal
axis represent the q telomere of the chromosomes. The BACs are ordered by position in the genome
beginning at 1p and ending at Xq.
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Figure 5: Array-CGH profile of chromosome 20 of S1514. The x-axis represents clonal distance in Mb
from the p telomere. The broken vertical lines represent transition points. High-level amplifications are
shown using N.
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Figure 6: Array-CGH profile of chromosome 13 of GBM31. The clonal distance in Mb from the p
telomere is plotted on the x-axis. High-level amplifications and outliers are respectively indicated using
N and H. The broken vertical line represents a transition point.
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Figure 7: Partial array-CGH profile of chromosome 7 of GBM29. The clonal distance in Mb from the p
telomere is plotted on the x-axis. High-level amplifications and outliers are respectively indicated using
N and H.
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Figure 8: Estimated means Ê[µj |Y ] for three independently generated data sets (shown by solid, dashed
and dotted lines) plotted against ².
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Figure 9: Examples from Section 4.1 where the Bayesian and non-Bayesian array-CGH profiles are
different. The upper panels correspond to chromosome 5 of sample 7 and the lower panels correspond
to chromosome 19 of sample 34. The clonal distance in Mb from the p telomere has been plotted on
the x-axis. High-level amplifications and outliers are indicated using N and H respectively. The broken
vertical lines represents transition points.
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Source
Chromosome Specimen
5
2
5
7
12
10
7
13
15
13
5
19
18
31
19
34

Bayesian HMM
SE
% accuracy
94.81
0.789
1.188
91.99
95.22
0.390
1.019
92.41
92.42
1.322
2.189
88.02
84.95
2.512
2.000
88.13

Non-Bayesian HMM
SE
% accuracy
86.89
1.685
1.942
81.44
89.08
1.378
2.333
80.09
82.55
1.649
2.873
73.09
71.17
2.448
2.124
72.10

Table 1: Estimated percentages of correctly discovered copy number states for the Bayesian and nonBayesian methods, along with the estimated standard errors. The estimates were based on 100 independently generated data sets. The first two columns specify the chromosome and specimen numbers
of the Section 4.1 data set whose the estimated hyperparameters were used to generate the data. See
the text for an explanation.

Source
Chromosome Specimen
13
33
19
4
14
1
12
17
1
24
3
35
23
12
15
34

Bayesian HMM
SE
% accuracy
94.38
1.203
1.129
88.20
87.35
1.893
1.736
80.84
40.64
2.512
0.239
96.03
74.31
3.417
2.164
90.79

Non-Bayesian HMM
SE
% accuracy
72.01
2.634
0.534
87.94
76.47
1.834
1.453
76.11
54.31
1.460
2.509
72.06
65.2
2.420
2.798
68.3

CBS
% accuracy
67.72
75.36
86.70
44.12
35.37
92.43
58.08
55.22

SE
3.512
1.726
0.426
1.791
2.470
0.488
3.311
4.175

Table 2: Estimated percentages of correctly discovered copy number states for the Bayesian and nonBayesian methods, along with the estimated standard errors. The estimates were based on 100 independently generated data sets. The first two columns specify the chromosome and specimen numbers
of the Section 4.1 data set whose the estimated hyperparameters were used to generate the data. See
the text for an explanation.
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